Follow the people · Insider

LK

Louise Frederika Kooij

Insider · Chief Accounting Officer · NAMS

Louise Frederika Kooij files insider transactions with the SEC as a chief accounting officer of NewAmsterdam Pharma Co (NAMS). We hold 8 disclosed purchases and sales filed since 3 January 2024, 2 of them in the last 90 days.

  • Files forNAMS
  • Disclosed buys and sells8 in all, 2 in the last 90 days
  • Last disclosure22 July 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 January 202420 July 2026Chief Accounting Officer · NewAmsterdam Pharma Co (NAMS)83 Form 4 lines · source: SEC Form 4

Everything they disclosed

83 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.